MetaADEDB 2.0 @ LMMD
Sugammadex
(KMGKABOMYQLLDJ-VKHHSAQNSA-F)
Structure
SMILES
[O-]C(=O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)[O-])O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]3[C@@H](CSCCC(=O)[O-])O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]3[C@@H](CSCCC(=O)[O-])O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]3[C@H](O[C@H](O[C@@H]4[C@H](O[C@H](O[C@@H]5[C@H](O[C@H](O[C@@H]6[C@H](O[C@H](O[C@H]1[C@@H]([C@H]2O)O)[C@H](O)[C@H]6O)CSCCC(=O)[O-])[C@H](O)[C@H]5O)CSCCC(=O)[O-])[C@H](O)[C@H]4O)CSCCC(=O)[O-])[C@@H]([C@H]3O)O)CSCCC(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
Molecular Formula:
C72H104Na8O48S8
Molecular Weight:
2178.010
Log P:
-18.3592
Hydrogen Bond Acceptor:
56
Hydrogen Bond Donor:
16
TPSA:
994.8
CAS Number(s):
343306-79-6
Synonym(s)
1.
Sugammadex
2.
6-Perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt
3.
Bridion
4.
Org 25969
5.
Sugammadex Sodium
External Link(s)
MeSHD000077122
PubChem Compound6918584
ChEBI90952
KEGGdr:D05940
Therapeutic Target DatabaseD08RID
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1BradycardiaFAERS: 64
Canada Vigilance: 2
Canada Vigilance
US FAERS
2BronchospasmFAERS: 27US FAERS
3HypotensionFAERS: 23US FAERS
4No adverse eventFAERS: 21US FAERS
5Cardiac ArrestFAERS: 17US FAERS
6Drug ineffectiveFAERS: 17US FAERS
7Anaphylactic shockFAERS: 11US FAERS
8Product use issueFAERS: 11US FAERS
9Adverse eventFAERS: 10US FAERS
10ErythemaFAERS: 10US FAERS
11TachycardiaFAERS: 9US FAERS
12HypoxiaFAERS: 8US FAERS
13AgitationFAERS: 7US FAERS
14Atrial FibrillationFAERS: 7US FAERS
15LaryngospasmFAERS: 7US FAERS
16Recurrence of neuromuscular blockadeFAERS: 7US FAERS
17HypoventilationFAERS: 6US FAERS
18Incorrect dose administeredFAERS: 6US FAERS
19Drug administered to patient of inappropriate ageFAERS: 5US FAERS
20Drug effect incompleteFAERS: 5US FAERS
21FlushingFAERS: 5US FAERS
22Product quality issueFAERS: 5US FAERS
23StridorFAERS: 5US FAERS
24UrticariaFAERS: 5US FAERS
25AngioedemaFAERS: 4US FAERS
26AstheniaFAERS: 4US FAERS
27Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
28DeliriumFAERS: 4US FAERS
29HypersensitivityFAERS: 4US FAERS
30NauseaFAERS: 4US FAERS
31Product barcode issueFAERS: 4US FAERS
32Respiratory arrestFAERS: 4US FAERS
33VomitingFAERS: 4US FAERS
34Chest discomfortFAERS: 3US FAERS
35CyanosisFAERS: 3US FAERS
36DisorientationFAERS: 3US FAERS
37Drug effect delayedFAERS: 3US FAERS
38Kounis SyndromeFAERS: 3US FAERS
39Lip swellingFAERS: 3US FAERS
40Musculoskeletal stiffnessFAERS: 3US FAERS
41PetechiaeFAERS: 3US FAERS
42Product label confusionFAERS: 3US FAERS
43ShockFAERS: 3US FAERS
44Unilateral bronchospasmFAERS: 3US FAERS
45Upper airway obstructionFAERS: 3US FAERS
46Ventricular FibrillationFAERS: 3US FAERS
47WheezingFAERS: 3US FAERS
48Agitation postoperativeFAERS: 2US FAERS
49AmnesiaFAERS: 2US FAERS
50Drug effect faster than expectedFAERS: 2US FAERS
51End-tidal CO2 increasedFAERS: 2US FAERS
52Endotracheal intubation complicationFAERS: 2US FAERS
53Maternal exposure during pregnancyFAERS: 2US FAERS
54Product container issueFAERS: 2US FAERS
55Product use in unapproved indicationFAERS: 2US FAERS
56PruritusFAERS: 2US FAERS
57Pulmonary arterial pressure increasedFAERS: 2US FAERS
58SomnolenceFAERS: 2US FAERS
59Subcutaneous EmphysemaFAERS: 2US FAERS
60Therapeutic product effect delayedFAERS: 2US FAERS
61Therapeutic response unexpectedFAERS: 2US FAERS
62Tidal VolumeFAERS: 2US FAERS
63Tidal volume decreasedFAERS: 2US FAERS
64TrismusFAERS: 2US FAERS
65Tryptase increasedFAERS: 2US FAERS
66Unresponsive to stimuliFAERS: 2US FAERS
67Urinary IncontinenceFAERS: 2US FAERS
68Vocal Cord ParalysisFAERS: 2US FAERS
69nervous system disorderFAERS: 2US FAERS
70Acute myocardial infarctionFAERS: 1US FAERS
71AlveolitisFAERS: 1US FAERS
72Anaphylactoid ReactionFAERS: 1US FAERS
73AnxietyFAERS: 1US FAERS
74Aortic InjuryFAERS: 1US FAERS
75AsphyxiaFAERS: 1US FAERS
76AsthmaFAERS: 1US FAERS
77Blood immunoglobulin E increasedFAERS: 1US FAERS
78Breast FeedingFAERS: 1US FAERS
79Bronchial ObstructionFAERS: 1US FAERS
80Contraindicated drug prescribedFAERS: 1US FAERS
81Coronary Artery DiseaseFAERS: 1US FAERS
82Depressed Level of ConsciousnessFAERS: 1US FAERS
83Device effect incompleteFAERS: 1US FAERS
84Drug administration errorFAERS: 1US FAERS
85EcchymosisFAERS: 1US FAERS
86Ectopic PregnancyFAERS: 1US FAERS
87EczemaFAERS: 1US FAERS
88EpilepsyFAERS: 1US FAERS
89ExtravasationFAERS: 1US FAERS
90Feeling abnormalFAERS: 1US FAERS
91Gaze palsyFAERS: 1US FAERS
92General physical health deteriorationFAERS: 1US FAERS
93Incorrect product storageFAERS: 1US FAERS
94Injection related reactionFAERS: 1US FAERS
95Injection site extravasationFAERS: 1US FAERS
96Injection site urticariaFAERS: 1US FAERS
97Intercepted medication errorFAERS: 1US FAERS
98Liquid product physical issueFAERS: 1US FAERS
99MalaiseFAERS: 1US FAERS
100Muscle RigidityFAERS: 1US FAERS
101Muscle enzyme increasedFAERS: 1US FAERS
102Nerve BlockFAERS: 1US FAERS
103Neuromuscular blocking therapyFAERS: 1US FAERS
104OverdoseFAERS: 1US FAERS
105PalpitationsFAERS: 1US FAERS
106PneumoniaFAERS: 1US FAERS
107Poor quality drug administeredFAERS: 1US FAERS
108Post procedural complicationFAERS: 1US FAERS
109Pre-existing condition improvedFAERS: 1US FAERS
110PresyncopeFAERS: 1US FAERS
111Product administered to patient of inappropriate ageFAERS: 1US FAERS
112Product container seal issueFAERS: 1US FAERS
113Prone PositionFAERS: 1US FAERS
114Respiratory DepressionFAERS: 1US FAERS
115RestlessnessFAERS: 1US FAERS
116Swelling of eyelidFAERS: 1US FAERS
117SwellingFAERS: 1US FAERS
118Systemic lupus erythematosus rashFAERS: 1US FAERS
119TachyarrhythmiaFAERS: 1US FAERS
120Therapeutic product effect decreasedFAERS: 1US FAERS
121Tidal volume abnormalFAERS: 1US FAERS
122Tongue bitingFAERS: 1US FAERS
123Tooth ExtractionFAERS: 1US FAERS
124TorticollisFAERS: 1US FAERS
125Tracheal StenosisFAERS: 1US FAERS
126TremorFAERS: 1US FAERS
127Vagus Nerve DisorderFAERS: 1US FAERS
128VasospasmFAERS: 1US FAERS
129Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.